{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:06:54Z","timestamp":1771304814224,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":107,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.smim.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T03:31:11Z","timestamp":1370835071000},"page":"114-123","source":"Crossref","is-referenced-by-count":35,"title":["Vaccines for low-income countries"],"prefix":"10.1016","volume":"25","author":[{"given":"Calman A.","family":"MacLennan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2013.05.004_bib0005","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/CVI.00290-09","article-title":"Vaccines: the fourth century","volume":"16","author":"Plotkin","year":"2009","journal-title":"Clinical Vaccine Immunology"},{"key":"10.1016\/j.smim.2013.05.004_bib0010","series-title":"The global burden of disease: 2004 update","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0015","first-page":"15","article-title":"The value of vaccination","volume":"6","author":"Bloom","year":"2005","journal-title":"World Economics"},{"key":"10.1016\/j.smim.2013.05.004_bib0020","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2010.11.090","article-title":"Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine","volume":"29","author":"Barnighausen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0030","series-title":"The GAVI Alliance","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0035","series-title":"Mr. Bill Gates, Co-chair of the Bill & Melinda Gates Foundation","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0040","series-title":"Immunization service delivery","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0045","series-title":"MMWR Morb Mortal Wkly Rep 59","first-page":"1367","article-title":"Global routine vaccination coverage, 2009","year":"2010"},{"issue":"Suppl. 1","key":"10.1016\/j.smim.2013.05.004_bib0050","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jcpa.2007.04.004","article-title":"The challenges of vaccine responses in early life: selected examples","volume":"137","author":"Siegrist","year":"2007","journal-title":"Journal of Comparative Pathology"},{"key":"10.1016\/j.smim.2013.05.004_bib0055","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1586\/erv.11.106","article-title":"Mucosal immunity to poliovirus","volume":"10","author":"Ogra","year":"2011","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.smim.2013.05.004_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0065","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.coi.2012.03.014","article-title":"Vaccines against mucosal infections","volume":"24","author":"Holmgren","year":"2012","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.smim.2013.05.004_bib0075","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2013.05.004_bib0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3201\/eid0906.030020","article-title":"Poor potential coverage for 7-valent pneumococcal conjugate vaccine","volume":"9","author":"Gordon","year":"2003","journal-title":"Emerging Infectious Diseases, Malawi"},{"key":"10.1016\/j.smim.2013.05.004_bib0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(11)60406-6","article-title":"The future of immunisation policy, implementation, and financing","volume":"378","author":"Levine","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2013.05.004_bib0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/11207130-000000000-00000","article-title":"Rotavirus vaccine RIX4414 (Rotarix): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries","volume":"29","author":"Plosker","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.smim.2013.05.004_bib0095","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/S0140-6736(11)60687-9","article-title":"Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines","volume":"378","author":"Hargreaves","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2013.05.004_bib0100","series-title":"Weekly Epidemiological Record, vol. 85","first-page":"434","article-title":"Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report","author":"WHO","year":"2010"},{"key":"10.1016\/j.smim.2013.05.004_bib0105","series-title":"Proceedings of the Tenth Global Vaccine Research Forum and Parallel Satellite Symposia","author":"WHO","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0110","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0115","series-title":"The Mengitis Vaccine Project","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","author":"Novak","year":"2012","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0125","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","author":"Kristiansen","year":"2012","journal-title":"Clinical Infectious Disease"},{"key":"10.1016\/j.smim.2013.05.004_bib0130","series-title":"PATH Malaria Vaccine Initiative","author":"Anonymous","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0135","series-title":"Global HIV Vaccine Enterprise","author":"Anonymous","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0140","series-title":"Aeras","author":"Anonymous","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0145","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of Phase 3 trial of RTS, S\/AS01 malaria vaccine in African children","volume":"365","author":"Agnandji","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0150","article-title":"A Phase 3 trial of RTS, S\/AS01 malaria vaccine in African infants","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0155","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.coi.2012.04.006","article-title":"HIV vaccine design: the neutralizing antibody conundrum","volume":"24","author":"Stamatatos","year":"2012","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.smim.2013.05.004_bib0160","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","article-title":"Tuberculosis vaccines: beyond bacille Calmette-Guerin","volume":"366","author":"McShane","year":"2011","journal-title":"Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences"},{"key":"10.1016\/j.smim.2013.05.004_bib0165","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1098\/rstb.2011.0033","article-title":"Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries","volume":"366","author":"Clemens J","year":"2011","journal-title":"Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences"},{"key":"10.1016\/j.smim.2013.05.004_bib0170","series-title":"Global Enterics Multi-Center Study","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0175","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QCO.0b013e328356ffeb","article-title":"Vaccines for typhoid fever and other salmonelloses","volume":"25","author":"Martin","year":"2012","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0180","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0185","doi-asserted-by":"crossref","first-page":"e47039","DOI":"10.1371\/journal.pone.0047039","article-title":"O:2-CRM(197) conjugates against Salmonella Paratyphi A","volume":"7","author":"Micoli","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2013.05.004_bib0190","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/hv.19158","article-title":"Glycoconjugate vaccine strategies for protection against invasive Salmonella infections","volume":"8","author":"Simon","year":"2012","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.smim.2013.05.004_bib0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/QCO.0b013e3282f88b92","article-title":"Shigellosis: the current status of vaccine development","volume":"21","author":"Kweon","year":"2008","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrgastro.2011.174","article-title":"New-generation vaccines against cholera","volume":"8","author":"Clemens","year":"2011","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.smim.2013.05.004_bib0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0210","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-065X.2010.00976.x","article-title":"Vaccines to combat the neglected tropical diseases","volume":"239","author":"Bethony","year":"2011","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.smim.2013.05.004_bib0220","series-title":"Sabin Vaccine Institute","author":"Anonymous","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0225","series-title":"International Vaccine Institute","author":"Anonymous","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0230","series-title":"Novartis Vaccines Institute for Global Health","author":"Anonymous","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0235","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3855\/T2.2.154","article-title":"The Novartis Vaccines Institute for Global Health: a new initiative for developing vaccines for neglected diseases in developing countries","volume":"2","author":"Saul","year":"2008","journal-title":"Journal of Infection in Developing Countries"},{"key":"10.1016\/j.smim.2013.05.004_bib0240","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, immunogenicity and dose ranging of a new Vi-CRM conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults","volume":"6","author":"van","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2013.05.004_bib0245","series-title":"Hilleman Laboratories","author":"Anonymous","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(99)03366-8","article-title":"Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa","volume":"355","author":"Woods","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2013.05.004_bib0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.smim.2013.05.004_bib0260","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/S0264-410X(99)00139-5","article-title":"Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood","volume":"17","author":"MacLennan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0265","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/CVI.05020-11","article-title":"Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers","volume":"18","author":"Findlow","year":"2011","journal-title":"Clinical Vaccine Immunology"},{"key":"10.1016\/j.smim.2013.05.004_bib0270","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0275","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000624","article-title":"Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus","volume":"2","author":"Khurana","year":"2010","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0280","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0285","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.smim.2013.05.004_bib0290","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.smim.2013.05.004_bib0295","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2013.05.004_bib0300","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.smim.2013.05.004_bib0305","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.smim.2013.05.004_bib0310","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0315","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development","volume":"5","author":"Pajon","year":"2011","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0320","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.015693","article-title":"Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case","volume":"11","author":"Bensi","year":"2012","journal-title":"Molecular and Cellular Proteomics"},{"key":"10.1016\/j.smim.2013.05.004_bib0325","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrmicro1552","article-title":"Group B Streptococcus: global incidence and vaccine development","volume":"4","author":"Johri","year":"2006","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.smim.2013.05.004_bib0330","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1073\/pnas.0915077107","article-title":"Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli","volume":"107","author":"Moriel","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.smim.2013.05.004_bib0335","doi-asserted-by":"crossref","first-page":"e35616","DOI":"10.1371\/journal.pone.0035616","article-title":"High yield production process for Shigella outer membrane particles","volume":"7","author":"Berlanda","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.smim.2013.05.004_bib0340","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annual Review of Microbiology"},{"key":"10.1016\/j.smim.2013.05.004_bib0345","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/pmic.200500164","article-title":"Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles","volume":"6","author":"Ferrari","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.smim.2013.05.004_bib0350","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.2007.132571","article-title":"Phase II meningococcal B vesicle vaccine trial in New Zealand infants","volume":"94","author":"Jackson","year":"2009","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.smim.2013.05.004_bib0355","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/CVI.00542-10","article-title":"A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccines","volume":"18","author":"Koeberling","year":"2011","journal-title":"Clinical Vaccine Immunology"},{"key":"10.1016\/j.smim.2013.05.004_bib0360","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1016\/j.vaccine.2011.04.095","article-title":"Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys","volume":"29","author":"Koeberling","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0365","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2011.11.084","article-title":"Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide","volume":"30","author":"Zollinger","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0370","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2011.11.108","article-title":"Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi","volume":"30","author":"Micoli","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0375","series-title":"Immunization Standards. A system for the prequalification of vaccines for UN supply","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0380","series-title":"Immunization Standards. Meningococcal A conjugate 10 dose presentation","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0385","series-title":"Immunization Standards. Inactivated oral cholera","year":"2012"},{"key":"10.1016\/j.smim.2013.05.004_bib0390","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.smim.2013.05.004_bib0395","article-title":"Desirable attributes of vaccines for deployment in low-resource settings","author":"Chen","year":"2012","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.smim.2013.05.004_bib0400","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/17425247.4.5.459","article-title":"Needle-free vaccine delivery","volume":"4","author":"Kersten","year":"2007","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.smim.2013.05.004_bib0405","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/INF.0b013e3181958755","article-title":"Burden of neonatal infections in developing countries: a review of evidence from community-based studies","volume":"28","author":"Thaver","year":"2009","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.smim.2013.05.004_bib0410","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.ajog.2012.06.070","article-title":"Benefits of influenza vaccination during pregnancy for pregnant women","volume":"207","author":"Jamieson","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.smim.2013.05.004_bib0415","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.2369","article-title":"Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe","volume":"44","author":"Holt","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.smim.2013.05.004_bib0420","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ng.195","article-title":"High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi","volume":"40","author":"Holt","year":"2008","journal-title":"Nature Genetics"},{"key":"10.1016\/j.smim.2013.05.004_bib0425","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ng.2423","article-title":"Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa","volume":"44","author":"Okoro","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.smim.2013.05.004_bib0430","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic regulation of immune responses to vaccines in early life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.smim.2013.05.004_bib0435","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrg3114","article-title":"Human genetic susceptibility to infectious disease","volume":"13","author":"Chapman","year":"2012","journal-title":"Nature Reviews Genetics"},{"key":"10.1016\/j.smim.2013.05.004_bib0440","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1098\/rstb.2011.0275","article-title":"Evolution, revolution and heresy in the genetics of infectious disease susceptibility","volume":"367","author":"Hill","year":"2012","journal-title":"Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences"},{"key":"10.1016\/j.smim.2013.05.004_bib0445","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1473-3099(10)70072-4","article-title":"Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis","volume":"10","author":"Reddy","year":"2010","journal-title":"Lancet Infectious Diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0450","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(11)61752-2","article-title":"Invasive non-typhoidal Salmonella disease: an emerging and neglected tropical disease in Africa","volume":"379","author":"Feasey","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2013.05.004_bib0455","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/infdis\/155.6.1319","article-title":"Plasmodium falciparum malaria and Salmonella infections in Gambian children","volume":"155","author":"Mabey","year":"1987","journal-title":"The Journal of infectious diseases"},{"key":"10.1016\/j.smim.2013.05.004_bib0460","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1016\/j.vaccine.2011.06.006","article-title":"Coalition against Typhoid (CaT): a new, global initiative to advance typhoid vaccination","volume":"29","author":"Nelson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2013.05.004_bib0465","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2009.10.010","article-title":"Lymphocyte subsets in healthy Malawians: implications for immunologic assessment of HIV infection in Africa","volume":"125","author":"Mandala","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453231300033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104453231300033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T21:52:59Z","timestamp":1563141179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104453231300033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S104453231300033X"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2013.05.004","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}